BRAF and melanoma: Laurenzana et al. showed that BRAF-mutated melanoma cells with different uPAR expression levels have different sensitivities to verofenil; high levels of uPAR decrease the sensitivity of BRAF-mutated melanoma cells to verofenil, while a reduction in uPAR expression restores the sensitivity of drug-resistant cells to verofenil [99].